Novartis Investigative Site

East Providence, Rhode Island 02941

0 studies enrolling now · 5 studies all time

What they study most

Asthma, Chronic Obstructive Pulmonary Disease, Multiple Myeloma

Studies at this site

• Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment — Stopped early
• Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. — Completed
• Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma — Completed
• NVA237 BID Versus Placebo Twelve-week Efficacy Study — Completed
• 1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD) — Completed